| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sepsis | 13 | 2022 | 233 | 4.400 |
Why?
|
| MicroRNAs | 9 | 2022 | 447 | 3.210 |
Why?
|
| Lipopolysaccharides | 19 | 2019 | 455 | 2.780 |
Why?
|
| Pericytes | 5 | 2022 | 81 | 2.370 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 4 | 2022 | 106 | 2.230 |
Why?
|
| Inflammation | 13 | 2020 | 1030 | 1.830 |
Why?
|
| Arrestins | 4 | 2013 | 92 | 1.460 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 5 | 2011 | 47 | 1.410 |
Why?
|
| Endothelial Progenitor Cells | 2 | 2019 | 15 | 1.320 |
Why?
|
| Mice | 30 | 2022 | 8472 | 1.260 |
Why?
|
| Endothelial Cells | 3 | 2020 | 384 | 1.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 13 | 2019 | 626 | 1.040 |
Why?
|
| Lung | 7 | 2021 | 849 | 1.020 |
Why?
|
| Cytokines | 9 | 2022 | 866 | 1.010 |
Why?
|
| Animals | 34 | 2022 | 20877 | 0.980 |
Why?
|
| Endotoxemia | 5 | 2015 | 27 | 0.970 |
Why?
|
| Staphylococcus aureus | 7 | 2007 | 175 | 0.950 |
Why?
|
| Cell Line | 7 | 2021 | 1752 | 0.950 |
Why?
|
| Chemokine CXCL12 | 2 | 2014 | 51 | 0.890 |
Why?
|
| Gene Expression Regulation | 6 | 2020 | 1293 | 0.850 |
Why?
|
| Mice, Knockout | 12 | 2022 | 1692 | 0.850 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 3 | 2012 | 15 | 0.830 |
Why?
|
| Chemokines | 4 | 2020 | 119 | 0.790 |
Why?
|
| RNA, Long Noncoding | 1 | 2022 | 54 | 0.790 |
Why?
|
| Exosomes | 2 | 2019 | 44 | 0.780 |
Why?
|
| Circulating MicroRNA | 1 | 2020 | 9 | 0.740 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 69 | 0.740 |
Why?
|
| Caspase 1 | 1 | 2019 | 22 | 0.680 |
Why?
|
| Shock | 1 | 2019 | 28 | 0.680 |
Why?
|
| Macrophages, Peritoneal | 6 | 2012 | 67 | 0.670 |
Why?
|
| Acute Lung Injury | 1 | 2019 | 35 | 0.670 |
Why?
|
| Toll-Like Receptor 4 | 6 | 2015 | 114 | 0.660 |
Why?
|
| Cognitive Dysfunction | 1 | 2022 | 176 | 0.660 |
Why?
|
| Disease Models, Animal | 9 | 2022 | 2550 | 0.650 |
Why?
|
| Drug Carriers | 1 | 2019 | 90 | 0.650 |
Why?
|
| Interleukin-6 | 6 | 2015 | 330 | 0.630 |
Why?
|
| Inflammation Mediators | 3 | 2020 | 244 | 0.620 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 282 | 0.620 |
Why?
|
| Multiple Organ Failure | 2 | 2020 | 36 | 0.610 |
Why?
|
| Shock, Septic | 2 | 2015 | 101 | 0.600 |
Why?
|
| Cecum | 6 | 2019 | 39 | 0.600 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 563 | 0.580 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2012 | 34 | 0.570 |
Why?
|
| Endotoxins | 2 | 2008 | 76 | 0.560 |
Why?
|
| NF-kappa B | 5 | 2020 | 432 | 0.540 |
Why?
|
| Nanoparticles | 1 | 2019 | 254 | 0.540 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2014 | 21 | 0.500 |
Why?
|
| Spleen | 4 | 2014 | 301 | 0.480 |
Why?
|
| Macrophages | 7 | 2020 | 647 | 0.470 |
Why?
|
| Interferon Type I | 2 | 2022 | 32 | 0.430 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 234 | 0.430 |
Why?
|
| Receptors, CXCR4 | 1 | 2012 | 48 | 0.420 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2012 | 34 | 0.410 |
Why?
|
| Arthritis, Experimental | 1 | 2011 | 38 | 0.400 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2008 | 150 | 0.390 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2008 | 147 | 0.390 |
Why?
|
| beta-Arrestins | 4 | 2013 | 80 | 0.390 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2011 | 155 | 0.370 |
Why?
|
| Peroxidase | 3 | 2019 | 40 | 0.360 |
Why?
|
| Mice, Transgenic | 3 | 2022 | 1032 | 0.340 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 938 | 0.340 |
Why?
|
| Ligation | 2 | 2019 | 83 | 0.340 |
Why?
|
| Prognosis | 3 | 2020 | 2093 | 0.330 |
Why?
|
| Blotting, Western | 5 | 2019 | 954 | 0.320 |
Why?
|
| Humans | 24 | 2022 | 68525 | 0.310 |
Why?
|
| Interleukin-10 | 3 | 2014 | 144 | 0.300 |
Why?
|
| Streptococcus agalactiae | 1 | 2007 | 26 | 0.300 |
Why?
|
| Signal Transduction | 8 | 2020 | 2688 | 0.300 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2019 | 222 | 0.300 |
Why?
|
| Oligopeptides | 2 | 2010 | 152 | 0.290 |
Why?
|
| Lysophospholipids | 1 | 2008 | 209 | 0.290 |
Why?
|
| beta-Glucans | 1 | 2006 | 18 | 0.290 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 248 | 0.290 |
Why?
|
| Biomarkers | 3 | 2018 | 1593 | 0.280 |
Why?
|
| Cells, Cultured | 7 | 2018 | 2673 | 0.280 |
Why?
|
| beta-Arrestin 2 | 3 | 2011 | 29 | 0.270 |
Why?
|
| GTP-Binding Proteins | 1 | 2006 | 231 | 0.270 |
Why?
|
| Membrane Proteins | 2 | 2020 | 617 | 0.270 |
Why?
|
| Liver | 3 | 2019 | 1118 | 0.270 |
Why?
|
| Gram-Positive Bacteria | 1 | 2005 | 23 | 0.260 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 370 | 0.260 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2019 | 209 | 0.260 |
Why?
|
| Kidney | 3 | 2019 | 945 | 0.250 |
Why?
|
| Peptides | 2 | 2011 | 455 | 0.250 |
Why?
|
| Transcription Factor AP-1 | 1 | 2004 | 61 | 0.250 |
Why?
|
| Monocytes | 2 | 2020 | 210 | 0.250 |
Why?
|
| Drug Tolerance | 1 | 2004 | 80 | 0.240 |
Why?
|
| HMGB1 Protein | 3 | 2019 | 23 | 0.240 |
Why?
|
| Streptococcus | 1 | 2003 | 15 | 0.230 |
Why?
|
| Coronavirus 229E, Human | 1 | 2022 | 2 | 0.220 |
Why?
|
| src-Family Kinases | 1 | 2003 | 91 | 0.220 |
Why?
|
| Serpins | 2 | 2015 | 205 | 0.220 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2002 | 13 | 0.220 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2002 | 22 | 0.220 |
Why?
|
| Pertussis Toxin | 3 | 2011 | 72 | 0.220 |
Why?
|
| Hemoglobin Subunits | 1 | 2022 | 4 | 0.220 |
Why?
|
| T-Lymphocytes | 2 | 2020 | 595 | 0.220 |
Why?
|
| Optic Disk | 1 | 2022 | 37 | 0.210 |
Why?
|
| Ocular Hypertension | 1 | 2022 | 43 | 0.210 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2002 | 100 | 0.210 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2020 | 101 | 0.210 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2020 | 1 | 0.200 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 86 | 0.200 |
Why?
|
| Autoimmune Diseases | 1 | 2022 | 186 | 0.190 |
Why?
|
| Endothelium | 1 | 2020 | 98 | 0.190 |
Why?
|
| Immunologic Memory | 1 | 2020 | 75 | 0.190 |
Why?
|
| Microfilament Proteins | 1 | 2021 | 102 | 0.190 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 190 | 0.190 |
Why?
|
| Hypertension | 2 | 2022 | 1531 | 0.190 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 196 | 0.180 |
Why?
|
| Survival Rate | 3 | 2019 | 1055 | 0.180 |
Why?
|
| Microvessels | 1 | 2020 | 43 | 0.180 |
Why?
|
| Trans-Activators | 1 | 2021 | 237 | 0.180 |
Why?
|
| RNA Interference | 1 | 2020 | 266 | 0.180 |
Why?
|
| Escherichia coli K12 | 1 | 2019 | 9 | 0.170 |
Why?
|
| Interleukin-18 | 1 | 2019 | 16 | 0.170 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2019 | 21 | 0.170 |
Why?
|
| Homeostasis | 2 | 2020 | 291 | 0.170 |
Why?
|
| Punctures | 1 | 2019 | 35 | 0.170 |
Why?
|
| Neutrophils | 1 | 2020 | 204 | 0.170 |
Why?
|
| Pyroptosis | 1 | 2018 | 8 | 0.170 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2019 | 42 | 0.170 |
Why?
|
| Trachea | 1 | 2019 | 48 | 0.170 |
Why?
|
| Acetylglucosamine | 1 | 2019 | 46 | 0.170 |
Why?
|
| Protein Isoforms | 2 | 2011 | 246 | 0.160 |
Why?
|
| Capillary Permeability | 1 | 2018 | 69 | 0.160 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 742 | 0.160 |
Why?
|
| Cognition | 1 | 2022 | 512 | 0.160 |
Why?
|
| Organ Specificity | 1 | 2018 | 167 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2019 | 219 | 0.160 |
Why?
|
| Survival Analysis | 2 | 2010 | 714 | 0.150 |
Why?
|
| Dendritic Cells | 1 | 2019 | 201 | 0.150 |
Why?
|
| Male | 8 | 2020 | 37281 | 0.150 |
Why?
|
| Cell Movement | 1 | 2020 | 630 | 0.150 |
Why?
|
| Fibroblasts | 2 | 2012 | 902 | 0.150 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 371 | 0.150 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2020 | 41 | 0.150 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 158 | 0.140 |
Why?
|
| Hyperlipidemias | 1 | 2016 | 90 | 0.140 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 113 | 0.140 |
Why?
|
| Models, Biological | 1 | 2020 | 981 | 0.140 |
Why?
|
| Up-Regulation | 1 | 2018 | 682 | 0.140 |
Why?
|
| Cell Communication | 1 | 2016 | 116 | 0.140 |
Why?
|
| Plasma | 1 | 2015 | 58 | 0.140 |
Why?
|
| Immune Tolerance | 2 | 2007 | 114 | 0.130 |
Why?
|
| Tobacco | 1 | 2016 | 161 | 0.130 |
Why?
|
| Cholesterol | 1 | 2016 | 331 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 2790 | 0.130 |
Why?
|
| Toll-Like Receptors | 2 | 2005 | 56 | 0.130 |
Why?
|
| Lipoproteins, LDL | 1 | 2016 | 343 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2020 | 2356 | 0.120 |
Why?
|
| Treatment Outcome | 2 | 2016 | 7028 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1851 | 0.110 |
Why?
|
| Lipopeptides | 1 | 2012 | 7 | 0.110 |
Why?
|
| Poly I-C | 1 | 2012 | 20 | 0.110 |
Why?
|
| Stem Cells | 1 | 2014 | 248 | 0.110 |
Why?
|
| Zymosan | 1 | 2012 | 12 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2015 | 232 | 0.110 |
Why?
|
| beta-Arrestin 1 | 1 | 2011 | 22 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 951 | 0.100 |
Why?
|
| Mice, Inbred DBA | 1 | 2011 | 120 | 0.100 |
Why?
|
| Wasp Venoms | 1 | 2011 | 8 | 0.100 |
Why?
|
| Bacterial Load | 1 | 2011 | 24 | 0.100 |
Why?
|
| Brain | 1 | 2022 | 2175 | 0.100 |
Why?
|
| PPAR delta | 1 | 2010 | 14 | 0.100 |
Why?
|
| Hemin | 1 | 2010 | 10 | 0.100 |
Why?
|
| Peritoneal Cavity | 1 | 2010 | 25 | 0.090 |
Why?
|
| Blood | 1 | 2010 | 40 | 0.090 |
Why?
|
| Caenorhabditis elegans | 1 | 2010 | 38 | 0.090 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 696 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 146 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2011 | 235 | 0.090 |
Why?
|
| Middle Aged | 2 | 2020 | 21119 | 0.090 |
Why?
|
| Autoantibodies | 2 | 2022 | 434 | 0.090 |
Why?
|
| Obesity | 1 | 2016 | 1074 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2010 | 215 | 0.080 |
Why?
|
| Bacteremia | 1 | 2010 | 155 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 181 | 0.080 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2008 | 67 | 0.080 |
Why?
|
| Smoking | 1 | 2016 | 1449 | 0.080 |
Why?
|
| Female | 3 | 2022 | 38015 | 0.080 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2007 | 12 | 0.080 |
Why?
|
| Chromones | 2 | 2006 | 33 | 0.080 |
Why?
|
| PPAR gamma | 1 | 2007 | 95 | 0.070 |
Why?
|
| Morpholines | 2 | 2006 | 79 | 0.070 |
Why?
|
| Interleukins | 1 | 2007 | 79 | 0.070 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2006 | 35 | 0.070 |
Why?
|
| Risk Factors | 1 | 2016 | 5719 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 2 | 2004 | 247 | 0.070 |
Why?
|
| Macrophage Activation | 1 | 2006 | 75 | 0.070 |
Why?
|
| Proteoglycans | 1 | 2006 | 103 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2010 | 718 | 0.070 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2006 | 62 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 189 | 0.070 |
Why?
|
| Transfection | 1 | 2007 | 782 | 0.070 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 156 | 0.060 |
Why?
|
| Blood Urea Nitrogen | 2 | 2015 | 65 | 0.060 |
Why?
|
| Genotype | 1 | 2007 | 785 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2004 | 1199 | 0.060 |
Why?
|
| Lymphocytes | 1 | 2005 | 228 | 0.060 |
Why?
|
| Aging | 1 | 2010 | 911 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 492 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2004 | 241 | 0.060 |
Why?
|
| Patient Acuity | 1 | 2022 | 17 | 0.060 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2002 | 11 | 0.060 |
Why?
|
| Baculoviridae | 1 | 2002 | 14 | 0.060 |
Why?
|
| Spodoptera | 1 | 2002 | 21 | 0.060 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 20 | 0.050 |
Why?
|
| Peptide Library | 1 | 2002 | 16 | 0.050 |
Why?
|
| Bacteriophages | 1 | 2002 | 24 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2002 | 124 | 0.050 |
Why?
|
| Sphingomyelins | 1 | 2022 | 106 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 1753 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 110 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 322 | 0.050 |
Why?
|
| Cell Division | 1 | 2002 | 541 | 0.050 |
Why?
|
| Ligands | 1 | 2002 | 317 | 0.050 |
Why?
|
| Ischemia | 1 | 2022 | 229 | 0.050 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 2020 | 8 | 0.050 |
Why?
|
| Sp1 Transcription Factor | 1 | 2020 | 21 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2020 | 59 | 0.050 |
Why?
|
| Vaccination | 1 | 2022 | 182 | 0.050 |
Why?
|
| Camptothecin | 1 | 2020 | 39 | 0.050 |
Why?
|
| NIH 3T3 Cells | 1 | 2020 | 65 | 0.050 |
Why?
|
| Binding Sites | 1 | 2002 | 631 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 183 | 0.050 |
Why?
|
| Retina | 1 | 2022 | 252 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2002 | 368 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 1082 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 170 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 510 | 0.040 |
Why?
|
| Protein Binding | 1 | 2002 | 1027 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 42 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 434 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2019 | 76 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 614 | 0.040 |
Why?
|
| Ceramides | 1 | 2022 | 578 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2022 | 1663 | 0.040 |
Why?
|
| Models, Animal | 1 | 2019 | 252 | 0.040 |
Why?
|
| Adult | 1 | 2015 | 21375 | 0.040 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2015 | 12 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2015 | 12 | 0.030 |
Why?
|
| Thromboxane B2 | 2 | 2006 | 108 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2015 | 43 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2015 | 137 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2019 | 1034 | 0.030 |
Why?
|
| Creatinine | 1 | 2015 | 243 | 0.030 |
Why?
|
| Creatine | 1 | 2014 | 30 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 215 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2014 | 233 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2014 | 102 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2014 | 382 | 0.030 |
Why?
|
| Cytochromes b | 1 | 2010 | 3 | 0.020 |
Why?
|
| Genes, Helminth | 1 | 2010 | 2 | 0.020 |
Why?
|
| Rats | 2 | 2010 | 5300 | 0.020 |
Why?
|
| Paraquat | 1 | 2010 | 8 | 0.020 |
Why?
|
| Succinate Dehydrogenase | 1 | 2010 | 13 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 60 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2010 | 21 | 0.020 |
Why?
|
| Sirtuins | 1 | 2010 | 16 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 52 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2010 | 63 | 0.020 |
Why?
|
| Luciferases | 1 | 2010 | 105 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 196 | 0.020 |
Why?
|
| Thiazoles | 1 | 2010 | 95 | 0.020 |
Why?
|
| Hypotension | 1 | 2010 | 74 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 94 | 0.020 |
Why?
|
| Longevity | 1 | 2010 | 59 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 137 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2010 | 152 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2010 | 305 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 507 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2007 | 31 | 0.020 |
Why?
|
| Anilides | 1 | 2007 | 16 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 498 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1640 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2007 | 203 | 0.020 |
Why?
|
| Androstadienes | 1 | 2006 | 41 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2010 | 753 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 2083 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2004 | 71 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2004 | 86 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2004 | 33 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2004 | 82 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2004 | 140 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 134 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 331 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 250 | 0.010 |
Why?
|